|
Ron has been in the pharmaceutical industry for 19 years, presently leading AustarPharma. Prior to his current role, Ron was employed at Bristol-Myers Squibb (BMS) as a Director of Global Product Development over five years. Ron has been responsible for pharmaceutical product development from exploratory development, preclinical, pre-formulation, drug delivery platform technologies, formulation, process, and scale up manufacturing toward commercialization. Ron has led many successful commercial launches, including projects that the R&D work was done in the US R&D center. The fruits of these projects were transferred to BMS's Chinese GMP facility in Shanghai for commercial manufacturing for the US market. In addition, Ron worked closely with marketing staff and frequently participated in the marketing activities. Through such activities, Ron received a sizeable amount of marketing experience. Ron also worked for Abbott Labs as a manager in product development, prior to BMS, where he has participated in several major commercial product developments, such as Lansoprazole (Pravecid) and Fenofibrate (Tricor). At Abbott, Ron has gained great experience in product life cycle management. Previous to Abbott, Ron worked for Wyeth (previously Cyanamid), where he contributed significantly from early development to full development. One of his key contributions was the development of Injectable Vertepofin Liposomes (Visudyne), one of the seven liposomal products approved by the FDA. Ron was the sole inventor of the patented liposomal technology for thus far the biggest (half billon dollar in sales) liposomal product in the world. During his years in the pharmaceutical industry, he has gained extensive experiences in drug delivery technologies and pharmaceutical dosage innovations. One aspect of his special expertise and research interests is water-insoluble drug delivery. He is the editor and author of the book Water-Insoluble Drug Formulation, published by CRC Press. Ron is an inventor for more than 15 issued and pending drug delivery technology and formulation patents. In addition, Ron has been a Grant Reviewer for NIH in Drug Delivery, Product Development and Manufacturing. Ron graduated with a PhD in Pharmaceutics from the University of Iowa in 1991 and an MBA in Marketing from Rutgers University in 2002. | 